Utilities Healthcare Sector

Paragon Care

Market Cap: AU$703.5m

Distributes medical equipment, devices, and consumable products in Australia, New Zealand, and Asia.

Bioventus

Market Cap: US$450.6m

A medical device company, focuses on relieving pain and addressing musculoskeletal therapies in the United States and internationally.

Claritev

Market Cap: US$450.0m

Provides data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the healthcare industry in the United States.

REGENXBIO

Market Cap: US$445.9m

A clinical-stage biotechnology company, provides gene therapies that deliver functional genes to cells with genetic defects in the United States.

Cullinan Therapeutics

Market Cap: US$442.6m

A clinical-stage biopharmaceutical company, develops therapies for autoimmune diseases and cancer in the United States.

Septerna

Market Cap: US$438.5m

A clinical-stage biotechnology company, discovers and develops G protein-coupled receptor (GPCR) oral small molecule products for the treatment of endocrinology, immunology and inflammation, and metabolic diseases.

Zenas BioPharma

Market Cap: US$438.0m

A clinical-stage biopharmaceutical company, engages in the development and commercialization of transformative immunology-based therapies.

Personalis

Market Cap: US$437.2m

Develops, markets, and sells advanced cancer genomic tests and services in the United States and internationally.

Capricor Therapeutics

Market Cap: US$431.5m

A clinical-stage biotechnology company, engages in the development of transformative cell and exosome-based therapeutics for treating duchenne muscular dystrophy (DMD) and other diseases with unmet medical needs in the United States.

Sage Therapeutics

Market Cap: US$431.5m

A biopharmaceutical company, develops and commercializes brain health medicines.

Amylyx Pharmaceuticals

Market Cap: US$431.4m

A clinical-stage pharmaceutical company, engages in the discovery and development of treatment options for neurodegenerative diseases and endocrine conditions in the United States.

Precigen

Market Cap: US$428.0m

A discovery and clinical-stage biopharmaceutical company, develops gene and cell therapies using precision technology to target diseases in areas of immuno-oncology, autoimmune disorders, and infectious diseases.

SIGA Technologies

Market Cap: US$427.9m

A commercial-stage pharmaceutical company, focuses on the health security market in the United States.

Tourmaline Bio

Market Cap: US$425.4m

Operates as a clinical biotechnology company that develops medicines for patients with life-altering immune and inflammatory diseases.

Oxford Biomedica

Market Cap: UK£320.1m

A contract development and manufacturing organization, focuses on delivering therapies to patients worldwide.

Treace Medical Concepts

Market Cap: US$422.7m

A medical technology company, designs, manufactures, and markets medical devices in the United States.

EyePoint Pharmaceuticals

Market Cap: US$421.8m

Engages in developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases.

PureTech Health

Market Cap: UK£314.2m

Engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States.

Verastem

Market Cap: US$417.1m

A development-stage biopharmaceutical company, focuses on developing and commercializing drugs for the treatment of cancer in the United States.

Northwest Biotherapeutics

Market Cap: US$416.6m

A biotechnology company, focuses on developing personalized immune therapies for cancer.

Knight Therapeutics

Market Cap: CA$577.8m

Focuses on acquiring, in-licensing, out-licensing, marketing, and commercializing prescription pharmaceutical products in Canada and Latin America.

Verve Therapeutics

Market Cap: US$412.7m

A clinical-stage company, develops gene editing medicines for patients to treat cardiovascular disease in the United States.

Standard BioTools

Market Cap: US$410.2m

Develops, manufactures, and sells a range of instrumentation, consumables, and services to scientists and biomedical researchers to develop therapeutics in the Americas, Europe, the Middle East, Africa, and the Asia pacific.

Surmodics

Market Cap: US$408.7m

Provides performance coating technologies for intravascular medical devices, and chemical and biological components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally.

Vitalhub

Market Cap: CA$569.0m

Provides technology and software solutions for health and human service providers in Canada, the United States, the United Kingdom, Australia, Western Asia, and internationally.

Maze Therapeutics

Market Cap: US$405.1m

A clinical stage biopharmaceutical company, develops small molecule precision medicines for the treatment of renal, cardiovascular, related metabolic diseases, and obesity in the United States.

Fortrea Holdings

Market Cap: US$402.0m

A contract research organization, provides biopharmaceutical product and medical device development solutions to pharmaceutical, biotechnology, and medical device customers worldwide.

Celcuity

Market Cap: US$401.8m

A clinical-stage biotechnology company, focuses on the development of targeted therapies for the treatment of various solid tumors in the United States.

MeiraGTx Holdings

Market Cap: US$401.0m

A clinical stage genetics medicines company, focusing on developing treatments for patients with serious diseases.

Sana Biotechnology

Market Cap: US$393.6m

A biotechnology company, focuses on utilizing engineered cells as medicines in the United States.

Tectonic Therapeutic

Market Cap: US$391.9m

A biotechnology company, focuses on the discovery and development of therapeutic proteins and antibodies to modulate the activity of G protein-coupled receptors (GPCRs).

Australian Clinical Labs

Market Cap: AU$610.9m

Provides pathology diagnostic services in Australia.

Organogenesis Holdings

Market Cap: US$390.7m

A regenerative medicine company, develops, manufactures, and commercializes products for the advanced wound care, and surgical and sports medicine markets in the United States.

Prothena

Market Cap: US$386.5m

A late-stage clinical biotechnology company, focuses on discovery and development of novel therapies to treat diseases caused by protein dysregulation in the United States.

AngioDynamics

Market Cap: US$381.7m

A medical technology company, engages in the design, manufacture, and sale of medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally.

Myriad Genetics

Market Cap: US$380.7m

A molecular diagnostic testing and precision medicine company, develops and provides molecular tests in the United States and internationally.